CAC
ELV icon

Core Alternative Capital’s Elevance Health ELV Stock Holding History

Core Alternative Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8
Closed -$2.58K – 257
2025
Q3 		$2.58K Sell
8
-83
-91% -$25.8K ﹤0.01% 228
2025
Q2 		$35.4K Hold
91
– – 0.01% 143
2025
Q1 		$39.6K Hold
91
– – 0.01% 139
2024
Q4 		$33.6K Sell
91
-24
-21% -$10K 0.01% 165
2024
Q3 		$59.8K Hold
115
– – 0.01% 140
2024
Q2 		$62.3K Hold
115
– – 0.01% 136
2024
Q1 		$59.6K Sell
115
-31
-21% -$15.4K 0.01% 137
2023
Q4 		$69K Buy
146
+9
+7% +$4.16K 0.01% 149
2023
Q3 		$59.7K Sell
137
-9
-6% -$4.08K 0.01% 174
2023
Q2 		$64.9K Sell
146
-169
-54% -$78K 0.01% 143
2023
Q1 		$145K Buy
315
+27
+9% +$12.8K 0.02% 103
2022
Q4 		$148K Sell
288
-50
-15% -$25.4K 0.02% 105
2022
Q3 		$154K Buy
338
+8
+2% +$3.83K 0.02% 97
2022
Q2 		$159K Buy
330
+20
+6% +$9.89K 0.04% 106
2022
Q1 		$152K Sell
310
-7,521
-96% -$3.44M 0.04% 103
2021
Q4 		$3.63M Sell
7,831
-1,422
-15% -$598K 0.73% 54
2021
Q3 		$3.45M Sell
9,253
-401
-4% -$152K 0.73% 55
2021
Q2 		$3.69M Buy
9,654
+1,267
+15% +$484K 0.86% 48
2021
Q1 		$3.01M Sell
8,387
-8,918
-52% -$2.87M 0.86% 50
2020
Q4 		$5.56M Buy
17,305
+143
+0.8% +$43.9K 1.66% 35
2020
Q3 		$4.61M Sell
17,162
-2,957
-15% -$796K 1.57% 42
2020
Q2 		$5.29M Sell
20,119
-159
-0.8% -$42.4K 1.65% 40
2020
Q1 		$4.6M Buy
20,278
+13,014
+179% +$3.55M 1.61% 43
2019
Q4 		$2.19M Buy
+7,264
New +$2M 2.01% 37

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Core Alternative Capital's ELV Position: Q4 2025 in Review

Core Alternative Capital sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 8 shares — an estimated $2.58K sold.

Core Alternative Capital first reported a position in ELV in Q4 2019 and held it in 24 quarters. The position peaked at $5.56M in Q4 2020. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Core Alternative Capital reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Core Alternative Capital sold 8 Elevance Health shares in Q4 2025, an estimated $2.58K.
  • Core Alternative Capital first reported a position in Elevance Health in Q4 2019 and held it in 24 quarters.
  • Core Alternative Capital's Elevance Health position peaked at $5.56M in Q4 2020.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Core Alternative Capital's 13F filing for Q4 2025, filed 2 Feb 2026.